Efficacy and pharmacokinetic evaluation of a novel anti-malarial compound (NP046) in a mouse model

Abstract

Even though the oral bioavailability of NP046 is low, its percentage parasite growth inhibition is promising, but in order to improve the oral bioavailability, structure-activity-relationship (SAR) optimization studies are currently being conducted.